103 related articles for article (PubMed ID: 12576232)
1. Upregulation of the apoptosis regulators cFLIP, CD95 and CD95 ligand in peripheral blood mononuclear cells in relapsing-remitting multiple sclerosis.
Gomes AC; Jönsson G; Mjörnheim S; Olsson T; Hillert J; Grandien A
J Neuroimmunol; 2003 Feb; 135(1-2):126-34. PubMed ID: 12576232
[TBL] [Abstract][Full Text] [Related]
2. Interferon-gamma augments CD95(APO-1/Fas) and pro-caspase-8 expression and sensitizes human vascular endothelial cells to CD95-mediated apoptosis.
Li JH; Kluger MS; Madge LA; Zheng L; Bothwell AL; Pober JS
Am J Pathol; 2002 Oct; 161(4):1485-95. PubMed ID: 12368221
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of CD95 apoptotic signaling by interferon-gamma in human osteoarthritic chondrocytes is associated with increased expression of FLICE inhibitory protein.
Grassi F; Piacentini A; Cristino S; Toneguzzi S; Facchini A; Lisignoli G
Arthritis Rheum; 2004 Feb; 50(2):498-506. PubMed ID: 14872492
[TBL] [Abstract][Full Text] [Related]
4. Rifampicin inhibits CD95-mediated apoptosis of Jurkat T cells via glucocorticoid receptors by modifying the expression of molecules regulating apoptosis.
Yerramasetti R; Gollapudi S; Gupta S
J Clin Immunol; 2002 Jan; 22(1):37-47. PubMed ID: 11958592
[TBL] [Abstract][Full Text] [Related]
5. Latent sensitivity to Fas-mediated apoptosis after CD40 ligation may explain activity of CD154 gene therapy in chronic lymphocytic leukemia.
Chu P; Deforce D; Pedersen IM; Kim Y; Kitada S; Reed JC; Kipps TJ
Proc Natl Acad Sci U S A; 2002 Mar; 99(6):3854-9. PubMed ID: 11891278
[TBL] [Abstract][Full Text] [Related]
6. High level of cFLIP correlates with resistance to death receptor-induced apoptosis in bladder carcinoma cells.
Jönsson G; Paulie S; Grandien A
Anticancer Res; 2003; 23(2B):1213-8. PubMed ID: 12820373
[TBL] [Abstract][Full Text] [Related]
7. Constitutive caspase activation and impaired death-inducing signaling complex formation in CD95-resistant, long-term activated, antigen-specific T cells.
Strauss G; Knape I; Melzner I; Debatin KM
J Immunol; 2003 Aug; 171(3):1172-82. PubMed ID: 12874203
[TBL] [Abstract][Full Text] [Related]
8. Decreased levels of CD95 and caspase-8 mRNA in multiple sclerosis patients with gadolinium-enhancing lesions on MRI.
Gomes AC; Morris M; Stawiarz L; Jönsson G; Putheti P; Bronge L; Link H; Hillert J
Neurosci Lett; 2003 Dec; 352(2):101-4. PubMed ID: 14625033
[TBL] [Abstract][Full Text] [Related]
9. Up-regulation of c-FLIPshort and reduction of activation-induced cell death in CD28-costimulated human T cells.
Kirchhoff S; Müller WW; Li-Weber M; Krammer PH
Eur J Immunol; 2000 Oct; 30(10):2765-74. PubMed ID: 11069056
[TBL] [Abstract][Full Text] [Related]
10. Induction of apoptosis in 9-nitrocamptothecin-treated DU145 human prostate carcinoma cells correlates with de novo synthesis of CD95 and CD95 ligand and down-regulation of c-FLIP(short).
Chatterjee D; Schmitz I; Krueger A; Yeung K; Kirchhoff S; Krammer PH; Peter ME; Wyche JH; Pantazis P
Cancer Res; 2001 Oct; 61(19):7148-54. PubMed ID: 11585748
[TBL] [Abstract][Full Text] [Related]
11. Cholangiocarcinomas express Fas ligand and disable the Fas receptor.
Que FG; Phan VA; Phan VH; Celli A; Batts K; LaRusso NF; Gores GJ
Hepatology; 1999 Dec; 30(6):1398-404. PubMed ID: 10573518
[TBL] [Abstract][Full Text] [Related]
12. Molecular basis of rifampicin-induced inhibition of anti-CD95-induced apoptosis of peripheral blood T lymphocytes: the role of CD95 ligand and FLIPs.
Gollapudi S; Jaidka S; Gupta S
J Clin Immunol; 2003 Jan; 23(1):11-22. PubMed ID: 12645856
[TBL] [Abstract][Full Text] [Related]
13. The development of clinical activity in relapsing-remitting MS is associated with a decrease of FasL mRNA and an increase of Fas mRNA in peripheral blood.
Lopatinskaya L; van Boxel-Dezaire AH; Barkhof F; Polman CH; Lucas CJ; Nagelkerken L
J Neuroimmunol; 2003 May; 138(1-2):123-31. PubMed ID: 12742662
[TBL] [Abstract][Full Text] [Related]
14. Regulation of the Fas death pathway by FLICE-inhibitory protein in primary human B cells.
Hennino A; Berard M; Casamayor-Pallejà M; Krammer PH; Defrance T
J Immunol; 2000 Sep; 165(6):3023-30. PubMed ID: 10975811
[TBL] [Abstract][Full Text] [Related]
15. TCR-mediated up-regulation of c-FLIPshort correlates with resistance toward CD95-mediated apoptosis by blocking death-inducing signaling complex activity.
Kirchhoff S; Müller WW; Krueger A; Schmitz I; Krammer PH
J Immunol; 2000 Dec; 165(11):6293-300. PubMed ID: 11086065
[TBL] [Abstract][Full Text] [Related]
16. NF-kappaB protects Behçet's disease T cells against CD95-induced apoptosis up-regulating antiapoptotic proteins.
Todaro M; Zerilli M; Triolo G; Iovino F; Patti M; Accardo-Palumbo A; di Gaudio F; Turco MC; Petrella A; de Maria R; Stassi G
Arthritis Rheum; 2005 Jul; 52(7):2179-91. PubMed ID: 15986355
[TBL] [Abstract][Full Text] [Related]
17. Deregulated c-Myc prematurely recruits both Type I and II CD95/Fas apoptotic pathways associated with terminal myeloid differentiation.
Amanullah A; Liebermann DA; Hoffman B
Oncogene; 2002 Feb; 21(10):1600-10. PubMed ID: 11896589
[TBL] [Abstract][Full Text] [Related]
18. Resistance to CD95/Fas-induced and ceramide-mediated apoptosis of human melanoma cells is caused by a defective mitochondrial cytochrome c release.
Raisova M; Bektas M; Wieder T; Daniel P; Eberle J; Orfanos CE; Geilen CC
FEBS Lett; 2000 May; 473(1):27-32. PubMed ID: 10802053
[TBL] [Abstract][Full Text] [Related]
19. MAPK/ERK signaling in activated T cells inhibits CD95/Fas-mediated apoptosis downstream of DISC assembly.
Holmström TH; Schmitz I; Söderström TS; Poukkula M; Johnson VL; Chow SC; Krammer PH; Eriksson JE
EMBO J; 2000 Oct; 19(20):5418-28. PubMed ID: 11032809
[TBL] [Abstract][Full Text] [Related]
20. c-FLIP mediates resistance of Hodgkin/Reed-Sternberg cells to death receptor-induced apoptosis.
Mathas S; Lietz A; Anagnostopoulos I; Hummel F; Wiesner B; Janz M; Jundt F; Hirsch B; Jöhrens-Leder K; Vornlocher HP; Bommert K; Stein H; Dörken B
J Exp Med; 2004 Apr; 199(8):1041-52. PubMed ID: 15078899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
